| # | Drug | Count |
|---|---|---|
| 0 | BRENSOCATIB | 69 |
| 1 | ALBUTEROL SULFATE | 47 |
| 2 | TOBRAMYCIN | 46 |
| 3 | AZITHROMYCIN DIHYDRATE | 36 |
| 4 | SODIUM CHLORIDE | 36 |
| 5 | SODIUM CHLORIDE TABLET | 35 |
| 6 | SODIUM CHLORIDE TABLETS | 35 |
| 7 | DORNASE ALFA | 30 |
| 8 | PREDNISONE | 30 |
| 9 | ERGOCALCIFEROL | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LIMONENE | 1 | 0.0909 |
| 1 | BRENSOCATIB | 69 | 0.0245 |
| 2 | NITAZOXANIDE | 3 | 0.0086 |
| 3 | ASPIRIN AND DIPYRIDAMOLE | 1 | 0.0041 |
| 4 | NAFCILLIN SODIUM | 3 | 0.0033 |
| 5 | CEFTOLOZANE AND TAZOBACTAM | 3 | 0.0031 |
| 6 | AZTREONAM | 17 | 0.0024 |
| 7 | OMADACYCLINE | 4 | 0.0023 |
| 8 | PSYLLIUM HUSK | 3 | 0.0022 |
| 9 | TOBRAMYCIN | 46 | 0.0019 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Human Deoxyribonuclease 1 [EPC] | 30 | 0.0015 |
| 1 | Aminoglycoside Antibacterial [EPC] | 68 | 0.0015 |
| 2 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 19 | 0.0011 |
| 3 | Tetracycline-class Antibacterial [EPC] | 5 | 0.0006 |
| 4 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 5 | Vitamin K [EPC] | 5 | 0.0006 |
| 6 | Bile Acid [EPC] | 10 | 0.0004 |
| 7 | Antimycobacterial [EPC] | 9 | 0.0004 |
| 8 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 9 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |